Normal and Pathological Red Cell Physiology

1. Relevance of Howell-Jolly body counts for measuring spleen function in sickle cell disease. Pourdieu C, El Hoss S, Le Roux E, Pages J, Koehl B, Missud M, Holvoet M, Ithier G, Benkerrou M, Haouari Z, Da Costa L, El Nemer W, Laurance S, Colin Aronovicz Y, Le Van Kim C, Fenneteau O, Lainey E, Brousse V. Am J Hematol. 2023 Feb 16. doi: 10.1002/ajh.26879

2. Molecular and structural characterization of a novel high-prevalence antigen of the Augustine blood group system. Vrignaud C, Mikdar M, Duval R, Reininger L,  Damaraju VL, Sawyer M, Colin Y, Le Van Kim C, Gelly JC, Etchebest C, Peyrard  T, Azouzi S. Transfusion. 2023 Feb 6. doi: 10.1111/trf.17268.

3. Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype. Koehl B, Vrignaud C, Mikdar M,  Nair TS, Yang L, Landry S, Laiguillon G, Giroux-Lathuile C, Anselme-Martin S, El Kenz H, Hermine O, Mohandas N,  Cartron JP, Colin Y, Detante O,  Marlu R, Le Van Kim C, Carey TH, Azouzi S, Peyrard T. EMBO Mol Med 2023 Jan 25;e16320. doi: 10.15252/emmm.202216320

4. β-Thalassemia in childhood: Current state of health in a high-income country. Donze C, Benoit A, Thuret I, Faust C; NaThalY Network; Gauthier A, Berbis J, Badens C, Brousse B. Br J Haematol 2023 Jan 6. doi: 10.1111/bjh.18631

5. Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology? Laurance S, Marin M, Colin Y. Int J Mol Sci . 2023 Jan 5;24(2):1072. doi: 10.3390/ijms24021072.

6. Persistence of chronic inflammation after regular blood transfusion therapy in sickle cell anemia. Dembele AK, Hermand P, Missud F, Lesprit E, Holvoet L,

Brousse V,,Ithier G, Odievre MH, Benkerrou M, Le Van Kim C and Koehl B. Blood Advances 2023. DOI 10.1182/bloodadvances.2022007464

7. Splenectomy in sickle cell disease: do benefits outweigh risks? Nardo-Marino A, and Brousse V.  Haematologica 2023. DOI 10.3324/haematol.2022.281587

8. Sickle Cell Disease Newborn Screening-An Audit of a Twin Island State. Belle Jarvis S, Hadeed E, Lee K, Hardy-Dessources MD, Knight-Madden JM and Richardson C. Int J Neonatal Screening 2023. DOI 10.3390/ijns9010014

9. Severity and burden of sickle cell disease in France: a nationwide   realworld study. Brousse V, Bernaudin F, Melaine A, Goguillot M, Gallagher M, Benard S and Habibi A. Haematologica 2023. DOI 10.3324/haematol.2022.282098

10. Adenosine signaling inhibits erythropoiesis and promotes myeloid differentiation. Mikdar M, Serra M, Colin E, Duval R, Gauthier EF, Lamarre Y, Colin Y, Le Van Kim C, Peyrard T, Koehl B and Azouzi S. Haematologica 2023. DOI 10.3324/haematol.2022.281823

11. Early splenectomy in a large cohort of children with sickle cell anemia: risks and consequences. Mechraoui A, Ithier G, Pages J, Haouari Z, Ali L, Bonnard A, Benkerrou M, Missud F, Koehl B, Holvoet L, Le Roux E and Brousse V. Haematologica 2023.DOI 10.3324/haematol.2022.282556

12. Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress. Esperti S, Nader E, Stier A, Boisson C, Carin R, Marano M, Robert M, Martin M, Horand F, Cibiel A, Renoux C, Van Bruggen R, Blans C, Dargaud Y, Joly P, Gauthier A, Poutrel S, Romana M, Roussel D and Connes P.  Haematologica 2023. DOI10.3324/haematol.2023.282684

13. Physiology of Red Cell Lineage: From Erythroblast Progenitors to Mature Red Blood Cell. Ducamp S and Ostuni MA.  Int J Mol Sci 2023. DOI 10.3390/ijms24119715

14. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission Piel FB, Rees DV, DeBaun MR, Nnodu O, Ranque B, Thompson AA, Ware RE, Abboud MR, Abraham A,  Ambrose EE, Andemariam B, Colah R, Colombatti R, Conran N, Costa FF, Cronin RM, de Montalembert M, Elion J, Esrick E, Greenway AL, Idris IM, Issom DZ, Jain D, Jordan LC, Kaplan ZS, King AA, Lloyd-Puryear M, Oppong SA, Sharma A, Sung L, Tshilolo L, Wilkie DJ,  Ohene-Frempong K. Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0.

15. Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study). Ranque B, Diaw M,  Dembele AK, Lapoumeroulie C, Offredo L, Tessougue O, Mourtalla Gueye S, Diallo D, Diop S, Colin-Aronovicz Y, Jouven X, Blanc-Brude O, Tharaux PL, Le Jeune S, Connes P, Romana M, Le Van Kim C. Br J Haematol 2023 Aug 15. doi: 10.1111/bjh.19006

16. Oxidative Stress in Healthy and Pathological Red Blood Cells. Orrico F, Laurance S, Lopez AC, Lefevre SD, Thomson L, Möller MN, Ostuni MA. Biomolecules 2023 Aug 18;13(8):1262. doi: 10.3390/biom13081262

17. Development of a new online SPE-HPLC-MS/MS method for the profiling and quantification of sphingolipids and phospholipids in red blood cells - Application to the study of Gaucher's disease. Bettioui T, Chipeaux C, Ben Arfa K, Héron S, Belmatoug N, Franco M, de Person M, Moussa F. Anal Chim Acta . 2023 Oct 16;1278:341719. doi: 10.1016/j.aca.2023.341719

18. Alpha hemolysin of E. coli induces hemolysis of human erythrocytes independently of toxin interaction with membrane proteins. Cané L, Saffioti NA, Genetet S, Daza Milone M, Ostuni MA, Schwarzbaum PJ, Mouro-Chanteloup I, Herlax V. Biochimie. 2023 Oct 9:S0300-9084(23)00271-7. doi: 10.1016/j.biochi.2023.10.008. Online ahead of print. 

19. Clinical studies on platelet transfusion: Time to consider methodological issues related to platelet counting. Mullier F, Baccini V, Lippi G, Lecompte T. Transfusion. 2023 Nov;63(11):2198-2200. doi: 10.1111/trf.17550

20. Clinical studies on platelet transfusion: Time to consider methodological issues related to platelet counting. Mullier F, Baccini V, Lippi G, Lecompte T. Transfusion. 2023 Nov;63(11):2198-2200. doi: 10.1111/trf.17550.

21. Duffy antigen is expressed during erythropoiesis in Duffy-negative individuals. Dechavanne C, Dechavanne S, Bosch J, Metral S, Redinger KR, Watson QD, Ratsimbasoa AC, Roeper B, Krishnan S, Fong R, Bennett S, Carias L, Chen E, Salinas ND, Ghosh A, Tolia NH, Woost PG, Jacobberger JW, Colin Y, Gamain B, King CL, Zimmerman PA. Cell Host Microbe. 2023 Dec 13;31(12):2093-2106.e7. doi: 10.1016/j.chom.2023.10.019.

22. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study. Rollé A, Vidal E, Laguette P, Garnier Y, Delta D, Martino F, Portecop P, Etienne-Julan M, Piednoir P, De Jong A, Romana M, Bernit E. Medicina (Kaunas). 2023 Dec 18;59(12):2196. doi: 10.3390/medicina59122196.